Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Step Pharma" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Step Pharma for you to read. Along with our medical data and news we also list Step Pharma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Step Pharma Companies for you to search.
BALLERUP, Denmark–(BUSINESS WIRE)–Today, LEO Pharma announced the sale of 10 products to Karo Pharma AB for 90 MEUR. The divested portfolio is non-core to LEO Pharma’s business, and was part of the portfolio acquired from Bayer in July 2019. “This divestment is an important step for LEO Pharma towards strategically aligning our portfolio and increasing …
Fard Johnmar, founder of Envision Solutions (a healthcare marketing communications consultancy) published my Pharma: Have No Fear Of The Blogosphere on his blog this morning. It’s another step in my continuing effort to get medical device manufacturers, big Pharma, and other “regulated products” providers to start corporate blogging. Lets see if it gets any discussions going.
Recent appointments at executive level in pharmaceutical and biotech companies include new CEOs at RhoVac AB, Step Pharma and Ascendis...
Each manual step in the process introduces the potential for errors, a fear for every pharma and medical device company.
Allan Hillgrove, the board member responsible for the company's human pharma and biopharma business, is set to retire at the end of the year as the rest of the Boehringer Ingelheim board is getting shaken up
Rhythm Pharmaceuticals (NASDAQ: RYTM) announced late Monday that president and CEO Keith Gottesdiener will step down from his executive roles and from the board of directors after the company submits its lead drug for FDA review. Gottesdiener has been Rhythm CEO and board member since 2011. A search for his successor is underway. Boston-based Rhythm’s […]
NICE Chief Sir Andrew Dillon to step down in 2020 http://bit.ly/2KZ3uAk #pharma #NHS pic.twitter.com/SWu9NF5j7V
Depending on the severity of kidney failure, the mortality rate ranges from 7% to as high as 80%, with an average rate of approximately 35%. Erik van den Berg, CEO of AM-Pharma tells PharmaVentures' CEO, Fintan Walton why this agreement is a significant step, not only for AM-Pharma and Pfizer, but also to the development of a potential treatment for Acute Kidney Injury and other inflammatory dise...
Gilead’s chief scientific officer, John McHutchison is to leave the company at the beginning of next month during a period of change at the big US pharma. CEO Daniel O’Day, formerly Roche’s pharma chief, took over at the beginning of March and is ...
BIO chief executive James Greenwood to step down after 2020 US elections http://bit.ly/2ItUClV #pharma
After more than 20 years of challenging pharma over drug prices, Sir Andrew Dillon is to step down as NICE’s chief executive next year. In a statement NICE said that Sir Andrew will leave the post at the end of March 2020, retiring after completin...
FDA provides "step-by-step instructions on how to convert" units of measure for folate, niacin and vitamins A, D and E...
Viren Mehta of Mehta Partners LLC mulls the potential of blockchain, the rapidly evolving IT resource that secures every step...
A decision from the FDA is now expected by mid-March after the agency accepted the pharma's application under priority review.
Pharma leader praises "laser focus" on thorny access questions
Abbott CEO to step down after 21 years http://bit.ly/2CNRYEk #pharma pic.twitter.com/rMonBjihsP
Lonza CEO to step down in 2020 http://bit.ly/35bpq3T #pharma pic.twitter.com/shtC7zK76z
On the one hand, step therapy protocols provide insurers with a way to negotiate lower drug costs. On the other, step therapy is considered an onerous condition of reimbursement, particularly given its fail-first implications.
Judge Robert Drain urged Purdue Pharma and the objecting states to take a break from court fights and talk about the advantages of standing down from suing the Sacklers, in exchange for cooperation from the family. Purdue called Drain’s order “an essential next step in preserving Purdue’s assets.”
Edison Investment Research - Pharmaceuticals & healthcare - Acacia Pharma: Acacia Pharma has announced that company founder Dr Julian Gilbert will step down on 31 July. As part of a planned succession, Michael Bolinder will be promoted to CEO and join the board of the company. Julian is expected to be available for a few months after the transition to help with the handover. Michael, who is based ...
So, you’ve done a few experiments and had fun with THP-1 cells, but now it’s time to translate those results to primary human monocytes. Isolating monocytes requires blood. Lots and lots of blood, depending on your downstream assay of choice. The yield can vary wildly by donor (if they had a cold at the time… The post Isolating Monocytes from Whole Blood: A Step-by-Step Guide appeared fi...
(MedPage Today) -- Step-by-step consideration of which adjuncts to use and when
Many areas of the UK are only just starting to explore the large-scale electronic care record projects that will be critical to delivering the integrated... The post A Step-by-Step Guide to Building the Northern Ireland Electronic Care Record appeared first on .
NICE Chief Sir Andrew Dillon to step down in 2020 http://bit.ly/2KZ3uAk #pharma pic.twitter.com/ySOZrV1y7J
Emerging from an activist investor fight, Amag announced a restructuring plan and 2020 sales estimates that fell short of Wall Street expectations.